Skip to main content

Table 1 Study Criteria

From: Oestrogen-deficiency induces bone loss by modulating CD14+ monocyte and CD4+ T cell DR3 expression and serum TL1A levels

Inclusion Criteria

Exclusion Criteria

Attending for first bone density scan

Recent fracture (in the past 3 months)

Adult

History of corticosteroid use (except inhaled or topical)

Female

Anti-TNF therapy

Post-Menopausal

Patients with known seropositive rheumatoid arthritis, inflammatory bowel disease

Recent history of continuous treatment with bisphosphonate, calcitonin, Strontium ranelate or parathyroid hormone (i.e. for more than 3 months)

Patients with known primary hyperparathyroidism

Currently taking part in another study